Cargando…
Exploratory analysis of the platelet-to-lymphocyte ratio prognostic value in the adjuvant renal cell cancer setting
AIM: To examine the prognostic value of the platelet-to-lymphocyte ratio (PLR) in the adjuvant renal cell carcinoma setting. MATERIALS & METHODS: Patients received adjuvant sunitinib (50 mg/day; 4 weeks on/2 weeks off) or placebo. The primary end point was disease-free survival (DFS). RESULTS: I...
Autores principales: | Patel, Anup, Ravaud, Alain, Motzer, Robert J, Pantuck, Allan J, Staehler, Michael, Escudier, Bernard, Martini, Jean-François, Lechuga, Mariajose, Lin, Xun, George, Daniel J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488532/ https://www.ncbi.nlm.nih.gov/pubmed/33028084 http://dx.doi.org/10.2217/fon-2020-0652 |
Ejemplares similares
-
Adjuvant sunitinib in patients with high-risk renal cell carcinoma: safety, therapy management, and patient-reported outcomes in the S-TRAC trial
por: Staehler, M, et al.
Publicado: (2018) -
Molecular characterization of renal cell carcinoma tumors from a phase III anti-angiogenic adjuvant therapy trial
por: Motzer, Robert J., et al.
Publicado: (2022) -
Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio in Branch Retinal Vein Occlusion
por: Zhu, Dan-dan, et al.
Publicado: (2019) -
The effect and correlation of smoking with platelet indices, neutrophil lymphocyte ratio and platelet lymphocyte ratio
por: Pujani, Mukta, et al.
Publicado: (2021) -
Evaluation of Neutrophil-Lymphocyte Ratios, Mean Platelet Volumes, and Platelet-Lymphocyte Ratios in Pterygium
por: Gokmen, Onur, et al.
Publicado: (2019)